RenMab mice have complete human antibody heavy and light chain variable regions in situ replaced for the development of fully human monoclonal antibodies with high diversity, high affinity, and low immunogenicity.
on this page
The binding affinity of RenMab™ derived antibodies is comparable to antibodies generated from wild - type mouse and chimeric antibodies.
